Straits Times Index
3,219.23 +14.41 (+0.45%) Nikkei
32,678.62 +276.21 (+0.85%) Hang Seng
17,762.43 -295.02 (-1.63%) FTSE 100
7,664.39 -19.52 (-0.25%) Bitcoin USD
26,105.20 -455.85 (-1.72%) CMC Crypto 200
558.39 -9.66 (-1.70%)
Sinovac Biotech Ltd. (SVA)
| Previous close | 6.47 |
| Open | N/A |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 6.47 - 6.47 |
| 52-week range | 6.47 - 6.47 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 642.437M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 6.66 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
BEIJING, September 11, 2023--Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its broad-spectrum neutralizing antibody product, the Anti-COVID-19 Antibody SA55 Injection ("SA55 Injection") in Beijing and has entered the phase II clinical trial in Shanghai after successfully enrolling its first participant recently.
- Business Wire
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
BEIJING, September 05, 2023--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the "Board of Directors") unanimously determined that the partial tender offer (the "Tender Offer") by Alternative Liquidity Index LP ("Alternative Liquidity") to acquire up to 10,000,000 common shares of Sinovac (the "Shares") for $0.03 per share in cash (the "Offer Price") is NOT advisable and is NO
- Business Wire
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
BEIJING, August 29, 2023--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, confirmed today that it is aware of an unsolicited partial tender offer from Alternative Liquidity Index LP to purchase up to a maximum of 10,000,000 shares of the Company, representing approximately 10.05% of the Company’s outstanding shares, for $0.03 per share in cash.
